Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Gmo

GMO Small Cap Quality Fund Class R6 (GMBVX)

Ticker GMBVX · · Holdings as of May 31, 2026

Expense ratio
0.76%$76/yr per $10k
1-yr return
−1.5%as of Dec 2025
Net assets
$702.0Mall share classes
Holdings
46

Bottom line

Is GMBVX a good fund? The bottom line

GMBVX is the Class R6 share class of GMO Small Cap Quality Fund, a managed small-cap mutual fund from Gmo.

Its expense ratio is 0.76% — about $76 a year on every $10,000 invested, cheaper than 78% of small-cap funds we track.

It returned −1.5% over one year (as of Dec 31, 2025, based on GMAWX, a share class of the same fund with nearly identical fees).

With $702 million in net assets and 46 holdings, its largest position is Aramark (4.8%) and the top 10 make up 38% of the portfolio.

What stands out

  • Low cost: cheaper than 78% of small-cap peers

Updated Nov 19, 2026

What GMBVX invests in

Total return.

GMO seeks to achieve the Funds investment objective by investing the Funds assets primarily in equities of U.S. small-cap companies that GMO believes to be of high quality. GMO believes a high quality company generally to be a company that has an established business that will deliver a high level of return on past investments and that will use cash flows to make investments with the potential for a high return on capital or to return cash to shareholders through dividends or share buybacks. In selecting securities for the Fund, GMO uses a combination of investment methods, typically considering both systematic factors, based on profitability, profit stability, leverage, and other publicly available financial information, and judgmental factors, based on GMOs assessment of future profitability, capital allocation, growth opportunities, and sustainability against competitive forces. GMO…

From the fund's prospectus (filed Oct 20, 2026).

GMBVX performance

Average annual total returns
1 yr5 yr10 yr
GMBVX−1.5%——
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full GMBVX performance history →

What GMBVX costs

On a $10,000 investment, GMBVX's 0.76% expense ratio costs about $76 a year. The prospectus estimates $1,008 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full GMBVX fee table →

GMBVX top 10 holdings

#Holding% of fund
1Aramark4.81%
2PriceSmart Inc4.73%
3Cirrus Logic Inc4.36%
4AAON Inc3.83%
5Balchem Corp3.59%
6Globus Medical Inc3.54%
7Clean Harbors Inc3.44%
8Ollie's Bargain Outlet Holdings Inc3.25%
9New York Times Co/The3.22%
10AptarGroup Inc3.20%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 38% of the fund. See all top 25 holdings and asset mix →

Alternatives to GMBVX

More funds like GMBVX →

GMBVX FAQ

What is the expense ratio of GMBVX?
GMBVX's expense ratio is 0.76%, which works out to about $76 a year for every $10,000 invested. The prospectus estimates total costs of $1,008 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is GMBVX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 78% of small-cap peers. This is general information, not personalized advice.
What does GMBVX hold?
GMBVX's largest holdings are Aramark (4.8%), PriceSmart Inc (4.7%), Cirrus Logic Inc (4.4%), AAON Inc (3.8%), Balchem Corp (3.6%). It holds 46 positions in total as of May 31, 2026 (SEC Form N-PORT).
Who manages GMBVX?
GMBVX is offered by Gmo through Gmo Trust.